Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (2024)

Table of Contents
List of references Publications that cite this publication References

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (1) https://doi.org/10.1371/journal.pone.0005724 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (2) Full text

Journal: PLoS ONE, 2009, №5, p.e5724

Publisher: Public Library of Science (PLoS)

Authors: Misagh Alipour, Zacharias E. Suntres, Majed Halwani, Ali O. Azghani, Abdelwahab Omri

List of references

  1. MP Boyle, Adult cystic fibrosis., JAMA, № 298, с. 1787
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (3) https://doi.org/10.1001/jama.298.15.1787
  2. MS Son, In vivo evidence of <italic>Pseudomonas aeruginosa</italic> nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients., Infect Immun, № 75, с. 5313
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (4) https://doi.org/10.1128/IAI.01807-06
  3. T Remmington, Oral anti-pseudomonal antibiotics for cystic fibrosis., Cochrane Database Syst Rev, № CD005405
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (5) https://doi.org/10.1002/14651858.CD005405.pub2
  4. T Lahiri, Approaches to the treatment of initial <italic>Pseudomonas aeruginosa</italic> infection in children who have cystic fibrosis., Clin Chest Med, № 28, с. 307
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (6) https://doi.org/10.1016/j.ccm.2007.02.003
  5. JM Courtney, Cytokines and inflammatory mediators in cystic fibrosis., J Cyst Fibros, № 3, с. 223
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (7) https://doi.org/10.1016/j.jcf.2004.06.006
  6. SM Kirov, Biofilm differentiation and dispersal in mucoid <italic>Pseudomonas aeruginosa</italic> isolates from patients with cystic fibrosis., Microbiology, № 153, с. 3264
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (8) https://doi.org/10.1099/mic.0.2007/009092-0
  7. TS Murray, <italic>Pseudomonas aeruginosa</italic> chronic colonization in cystic fibrosis patients., Curr Opin Pediatr, № 19, с. 83
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (9) https://doi.org/10.1097/MOP.0b013e3280123a5d
  8. SD Sagel, Sputum biomarkers of inflammation in cystic fibrosis lung disease., Proc Am Thorac Soc, № 4, с. 406
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (10) https://doi.org/10.1513/pats.200703-044BR
  9. A Elizur, Airway inflammation in cystic fibrosis., Chest, № 133, с. 489
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (11) https://doi.org/10.1378/chest.07-1631
  10. JA Driscoll, The epidemiology, pathogenesis and treatment of <italic>Pseudomonas aeruginosa</italic> infections., Drugs, № 67, с. 351
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (12) https://doi.org/10.2165/00003495-200767030-00003
  11. JR Iredell, Optimizing antipseudomonal therapy in critical care., Semin Respir Crit Care Med, № 28, с. 656
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (13) https://doi.org/10.1055/s-2007-996412
  12. CA Merlo, Incidence and risk factors for multiple antibiotic-resistant <italic>Pseudomonas aeruginosa</italic> in cystic fibrosis., Chest, № 132, с. 562
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (14) https://doi.org/10.1378/chest.06-2888
  13. JC Davies, Emerging and unusual gram-negative infections in cystic fibrosis., Semin Respir Crit Care Med, № 28, с. 312
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (15) https://doi.org/10.1055/s-2007-981652
  14. J Eisenberg, A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group., Chest, № 111, с. 955
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (16) https://doi.org/10.1378/chest.111.4.955
  15. T Hermann, Aminoglycoside antibiotics: old drugs and new therapeutic approaches., Cell Mol Life Sci, № 64, с. 1841
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (17) https://doi.org/10.1007/s00018-007-7034-x
  16. EM Westerman, Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study., J Cyst Fibros, № 6, с. 284
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (18) https://doi.org/10.1016/j.jcf.2006.10.010
  17. D Kaye, Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides., Infect Dis Clin North Am, № 18, с. 669
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (19) https://doi.org/10.1016/j.idc.2004.04.007
  18. CA Cannella, Acute renal failure associated with inhaled tobramycin., Am J Health Syst Pharm, № 63, с. 1858
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (20) https://doi.org/10.2146/ajhp060196
  19. SK Swan, Aminoglycoside nephrotoxicity., Semin Nephrol, № 17, с. 27
  20. B Fernandes, Duration of intravenous antibiotic therapy in people with cystic fibrosis., Cochrane Database Syst Rev, № CD006682
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (21) https://doi.org/10.1002/14651858.CD006682.pub2
  21. DJ Touw, Population pharmaco*kinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis., J Cyst Fibros, № 6, с. 327
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (22) https://doi.org/10.1016/j.jcf.2006.12.007
  22. ME Falagas, Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections., Clin Infect Dis, № 40, с. 1333
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (23) https://doi.org/10.1086/429323
  23. AP Zavascki, Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review., J Antimicrob Chemother, № 60, с. 1206
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (24) https://doi.org/10.1093/jac/dkm357
  24. EL Macfarlane, PhoP-PhoQ hom*ologues in <italic>Pseudomonas aeruginosa</italic> regulate expression of the outer-membrane protein OprH and polymyxin B resistance., Mol Microbiol, № 34, с. 305
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (25) https://doi.org/10.1046/j.1365-2958.1999.01600.x
  25. ME Sobieszczyk, Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections., J Antimicrob Chemother, № 54, с. 566
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (26) https://doi.org/10.1093/jac/dkh369
  26. A Chuchalin, A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and <italic>Pseudomonas aeruginosa</italic> infection: a double-blind, placebo-controlled, multicenter study., Paediatr Drugs, № 9, с. 21
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (27) https://doi.org/10.2165/00148581-200709001-00004
  27. J Govan, TOBI: reducing the impact of pseudomonal infection., Hosp Med, № 63, с. 421
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (28) https://doi.org/10.12968/hosp.2002.63.7.1987
  28. DE Geller, Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmaco*kinetics and safety., Pediatr Pulmonol, № 42, с. 307
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (29) https://doi.org/10.1002/ppul.20594
  29. G Lenoir, Efficacy, safety, and local pharmaco*kinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with <italic>Pseudomonas aeruginosa</italic>., Paediatr Drugs, № 9, с. 11
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (30) https://doi.org/10.2165/00148581-200709001-00003
  30. M Horianopoulou, Effect of aerosolized colistin on multidrug-resistant <italic>Pseudomonas aeruginosa</italic> in bronchial secretions of patients without cystic fibrosis., J Chemother, № 17, с. 536
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (31) https://doi.org/10.1179/joc.2005.17.5.536
  31. ME Hodson, A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis., Eur Respir J, № 20, с. 658
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (32) https://doi.org/10.1183/09031936.02.00248102
  32. MP Rogan, Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis., J Infect Dis, № 190, с. 1245
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (33) https://doi.org/10.1086/423821
  33. TS Walker, Enhanced <italic>Pseudomonas aeruginosa</italic> biofilm development mediated by human neutrophils., Infect Immun, № 73, с. 3693
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (34) https://doi.org/10.1128/IAI.73.6.3693-3701.2005
  34. R Ramphal, The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum., J Antimicrob Chemother, № 22, с. 483
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (35) https://doi.org/10.1093/jac/22.4.483
  35. SD Davis, Effects of sputum from patients with cystic fibrosis on the activity in vitro of 5 antimicrobial drugs on <italic>Pseudomonas aeruginosa</italic>., Am Rev Respir Dis, № 117, с. 176
  36. BE Hunt, Macromolecular mechanisms of sputum inhibition of tobramycin activity., Antimicrob Agents Chemother, № 39, с. 34
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (36) https://doi.org/10.1128/AAC.39.1.34
  37. A Someya, Interaction of aminoglycosides and other antibiotics with actin., J Antibiot (Tokyo), № 32, с. 156
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (37) https://doi.org/10.7164/antibiotics.32.156
  38. NN Sanders, Structural alterations of gene complexes by cystic fibrosis sputum., Am J Respir Crit Care Med, № 164, с. 486
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (38) https://doi.org/10.1164/ajrccm.164.3.2011041
  39. CA Vasconcellos, Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin., Science, № 263, с. 969
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (39) https://doi.org/10.1126/science.8310295
  40. A Kater, The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4., Ann N Y Acad Sci, № 1112, с. 140
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (40) https://doi.org/10.1196/annals.1415.006
  41. AJ Marshall, Interaction of divalent cations, quinolones and bacteria., J Antimicrob Chemother, № 34, с. 465
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (41) https://doi.org/10.1093/jac/34.4.465
  42. J Levy, Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum., J Infect Dis, № 148, с. 1069
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (42) https://doi.org/10.1093/infdis/148.6.1069
  43. DJ Weiner, The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin., Am J Respir Cell Mol Biol, № 28, с. 738
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (43) https://doi.org/10.1165/rcmb.2002-0191OC
  44. RM Landry, Mucin-<italic>Pseudomonas aeruginosa</italic> interactions promote biofilm formation and antibiotic resistance., Mol Microbiol, № 59, с. 142
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (44) https://doi.org/10.1111/j.1365-2958.2005.04941.x
  45. F Fabretti, Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides., Infect Immun, № 74, с. 4164
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (45) https://doi.org/10.1128/IAI.00111-06
  46. R Bucki, Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum., J Antimicrob Chemother, № 60, с. 535
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (46) https://doi.org/10.1093/jac/dkm218
  47. MI Lethem, The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum., Eur Respir J, № 3, с. 19
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (47) https://doi.org/10.1183/09031936.93.03010019
  48. MR Mozafari, Recent trends in the lipid-based nanoencapsulation of antioxidants and their role in foods., J Sci Food Agric, № 86, с. 2038
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (48) https://doi.org/10.1002/jsfa.2576
  49. MR Mozafari, Nanoliposomes and Their Applications in Food Nanotechnology., J Liposome Res, № 18, с. 309
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (49) https://doi.org/10.1080/08982100802465941
  50. M Halwani, Bactericidal efficacy of liposomal aminoglycosides against <italic>Burkholderia cenocepacia</italic>., J Antimicrob Chemother, № 60, с. 760
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (50) https://doi.org/10.1093/jac/dkm289
  51. A Omri, Enhanced activity of liposomal polymyxin B against <italic>Pseudomonas aeruginosa</italic> in a rat model of lung infection., Biochem Pharmacol, № 64, с. 1407
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (51) https://doi.org/10.1016/S0006-2952(02)01346-1
  52. SD Allison, Liposomal drug delivery., J Infus Nurs, № 30, с. 89
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (52) https://doi.org/10.1097/01.NAN.0000264712.26219.67
  53. NN Sanders, On the transport of lipoplexes through cystic fibrosis sputum., Pharm Res, № 19, с. 451
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (53) https://doi.org/10.1023/A:1015139527747
  54. P Meers, Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic <italic>Pseudomonas aeruginosa</italic> lung infections., J Antimicrob Chemother, № 61, с. 859
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (54) https://doi.org/10.1093/jac/dkn059
  55. NN Sanders, Cystic fibrosis sputum: a barrier to the transport of nanospheres., Am J Respir Crit Care Med, № 162, с. 1905
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (55) https://doi.org/10.1164/ajrccm.162.5.9909009
  56. H Ceri, The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms., J Clin Microbiol, № 37, с. 1771
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (56) https://doi.org/10.1128/JCM.37.6.1771-1776.1999
  57. M Alipour, Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains., Int J Pharm, № 355, с. 293
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (57) https://doi.org/10.1016/j.ijpharm.2007.11.035
  58. C Mugabe, Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of <italic>Pseudomonas aeruginosa</italic>., Antimicrob Agents Chemother, № 50, с. 2016
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (58) https://doi.org/10.1128/AAC.01547-05
  59. C Mugabe, Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibiotics., Int J Pharm, № 307, с. 244
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (59) https://doi.org/10.1016/j.ijpharm.2005.10.005
  60. TI Nicas, Outer membrane protein H1 of <italic>Pseudomonas aeruginosa</italic>: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin., J Bacteriol, № 143, с. 872
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (60) https://doi.org/10.1128/JB.143.2.872-878.1980
  61. RE Hanco*ck, Cationic peptides: effectors in innate immunity and novel antimicrobials., Lancet Infect Dis, № 1, с. 156
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (61) https://doi.org/10.1016/S1473-3099(01)00092-5
  62. SA Kharitonov, Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations., Contrib Microbiol, № 14, с. 83
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (62) https://doi.org/10.1159/000107056
  63. R Schiffelers, Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies., J Antimicrob Chemother, № 48, с. 333
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (63) https://doi.org/10.1093/jac/48.3.333
  64. R Bucki, Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum., Eur Respir J, № 29, с. 624
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (64) https://doi.org/10.1183/09031936.00080806
  65. JX Tang, Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum., Am J Physiol Lung Cell Mol Physiol, № 289, с. L599
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (65) https://doi.org/10.1152/ajplung.00061.2005
  66. VJ Broughton-Head, Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics., Pulm Pharmacol Ther, № 20, с. 708
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (66) https://doi.org/10.1016/j.pupt.2006.08.008
  67. JL Potter, Complex formation between basic antibiotics and deoxyribonucleic acid in human pulmonary secretions., Pediatrics, № 36, с. 714
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (67) https://doi.org/10.1542/peds.36.5.714
  68. M Davies, The binding of lipopolysaccharide from Escherichia coli to mammalian cell membranes and its effect on liposomes., Biochim Biophys Acta, № 508, с. 260
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (68) https://doi.org/10.1016/0005-2736(78)90329-2
  69. V Bataillon, The binding of amikacin to macromolecules from the sputum of patients suffering from respiratory diseases., J Antimicrob Chemother, № 29, с. 499
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (69) https://doi.org/10.1093/jac/29.5.499
  70. M Stern, The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro., Gene Ther, № 5, с. 91
    Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (70) https://doi.org/10.1038/sj.gt.3300556

Publications that cite this publication

Pulmonary Surfactant Preserves Viability of Alveolar Type II Cells Exposed to Polymyxin B In Vitro

Guido Stichtenoth, Egbert Herting, Mario Rüdiger, Andreas Wemhöner

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (71) https://doi.org/10.1371/journal.pone.0062105 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (72) Full text

2013, PLoS ONE, №4, p.e62105

Scopus

WoS

Crossref citations:1

Novel Formulations for Antimicrobial Peptides

Ana Carmona-Ribeiro, Letícia De Melo Carrasco

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (73) https://doi.org/10.3390/ijms151018040 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (74) Full text

2014, International Journal of Molecular Sciences, №10, p.18040-18083

Scopus

WoS

Crossref citations:108

Nanocarriers for combating biofilms: Advantages and challenges

Yuning Zhang, Shiyu Lin, Jingyuan Fu, Wei Zhang, Gang Shu, Juchun Lin, Haohuan Li, Funeng Xu, Huaqiao Tang, Guangneng Peng, Ling Zhao, Shiqi Chen, Hualin Fu

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (75) https://doi.org/10.1111/jam.15640 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (76)

2022, Journal of Applied Microbiology, №3, p.1273-1287

Scopus

WoS

Crossref citations:4

Targeted siRNA delivery to lung epithelia reduces airway inflammation in a mouse model of allergic asthma

Irfan Ullah, Hyo Sung Choi, Changseon Choi, Kunho Chung, Jae Wook Jung, Gyeongju Yun, Seoyoun Heo, Yujong Yi, Eunhwa Kang, Sang-Heon Kim, Ho Joo Yoon, Taiyoun Rhim, Sang-Kyung Lee

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (77) https://doi.org/10.1007/s12257-024-00027-3

2024, Biotechnology and Bioprocess Engineering, №1, p.97-108

Scopus

WoS

Crossref citations:0

Current World Literature

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (78) https://doi.org/10.1097/mcp.0b013e32834006f9 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (79)

2010, Current Opinion in Pulmonary Medicine, №6, p.623-627

Scopus

WoS

Crossref citations:0

Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives

Vijay Kumar Panthi, Kathryn E. Fairfull-Smith, Nazrul Islam

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (80) https://doi.org/10.1016/j.jddst.2024.105517

2024, Journal of Drug Delivery Science and Technology, p.105517

Scopus

WoS

Crossref citations:0

Why have trials of inhaled antibiotics for ventilator-associated infections failed?

Lucy B. Palmer

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (81) https://doi.org/10.1097/qco.0000000000000525 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (82)

2019, Current Opinion in Infectious Diseases, №2, p.163-168

Scopus

WoS

Crossref citations:6

Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles

Wean Sin Cheow, Kunn Hadinoto

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (83) https://doi.org/10.1016/j.partic.2011.08.007 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (84)

2012, Particuology, №3, p.327-333

Scopus

WoS

Crossref citations:51

Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients

Venkata Saran Solleti, Moayad Alhariri, Majed Halwani, Abdelwahab Omri

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (85) https://doi.org/10.1093/jac/dku452 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (86) Full text

2014, Journal of Antimicrobial Chemotherapy, №3, p.784-796

Scopus

WoS

Crossref citations:27

Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes

M. Alipour, Z. E. Suntres, R. M. Lafrenie, A. Omri

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (87) https://doi.org/10.1093/jac/dkq036 · Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (88) Full text

2010, Journal of Antimicrobial Chemotherapy, №4, p.684-693

Scopus

WoS

Crossref citations:40

Find all citations of the publication

About this publication

Number of citations 46
Number of works in the list of references 70
Journal indexed in Scopus Yes
Journal indexed in Web of Science Yes
Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis (2024)

References

Top Articles
107 242nd Court Southeast, Sammamish, WA 98074 | Compass
Iraqi Dinar Guru Updates, Investment, News, Opinions, and Intel (06-11-2024)
11 Key Things to Know When Renting a U-Haul Truck or Trailer
U-Haul’s U-Box Moving Container Review 2024 | Move.org
Neurology Clinic | Little Rock | UAMS Health
How Many Propane Tank Sizes Are There? | James O2
Integrated Primal Fire Wow
Ketchum Who's Gotta Catch Em All Crossword Clue
12 Cool Boutique Hotels in Atlanta, Georgia
Here Are the 18 Most Relaxing Spa Resorts in Georgia
Latest Posts
Swim lessons are hard to come by as pandemic eases - Sammamish Independent
Looking for last-minute swimming lessons? Here's what's available in Springfield, Nixa
Article information

Author: Merrill Bechtelar CPA

Last Updated:

Views: 6609

Rating: 5 / 5 (50 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Merrill Bechtelar CPA

Birthday: 1996-05-19

Address: Apt. 114 873 White Lodge, Libbyfurt, CA 93006

Phone: +5983010455207

Job: Legacy Representative

Hobby: Blacksmithing, Urban exploration, Sudoku, Slacklining, Creative writing, Community, Letterboxing

Introduction: My name is Merrill Bechtelar CPA, I am a clean, agreeable, glorious, magnificent, witty, enchanting, comfortable person who loves writing and wants to share my knowledge and understanding with you.